Horizon Oncology Research
Horizon Oncology Research
Lafayette, Indiana, United States1 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Safety, PK, and Preliminary Efficacy of MBRC-101 in Advanced Refractory Solid Tumors | cancer, neoplasm | Recruiting | Phase 1 / Phase 2 | 2026-03-02 | NCT06014658 |